Research demonstrates that machine learning improves predictive accuracy in biomarker discovery, implicating diverse omics data and functional genomics.
Key Points
Machine learning enhances biomarker discovery by integrating complex datasets, leading to improved predictive accuracy.
Using advanced AI techniques, biomarkers can be identified across various diseases, including oncology and autoimmune disorders.
Methodological developments focus on uncovering functional biomarkers like biosynthetic gene clusters essential for drug discovery.
Challenges like data quality and model interpretability remain, indicating caution for clinical implementation.